We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Advanced Oncotherapy Plc | LSE:AVO | London | Ordinary Share | GB00BD6SX109 | ORD 25P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 1.925 | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Medical Laboratories | 0 | -29.49M | -0.0549 | -0.35 | 10.32M |
TIDMAVO
RNS Number : 2377A
Advanced Oncotherapy PLC
22 December 2017
TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES(i) ------------------------------------------------------------------------------------------------------ 1. Identity of the issuer or the underlying Advanced Oncotherapy Plc issuer of existing shares to which voting rights are attached: (ii) ----------------------------------------------------------------------- ----------------------------- 2 Reason for the notification (please tick the appropriate box or boxes): ------------------------------------------------------------------------------------------------------ An acquisition or disposal of voting rights ü --------------------------------------------------------------------------- ------------------------- An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached --------------------------------------------------------------------------- ------------------------- An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments --------------------------------------------------------------------------- ------------------------- An event changing the breakdown of voting rights --------------------------------------------------------------------------- ------------------------- Other (please specify): ------------------------------------------------------------------- ------ ------------------------- 3. Full name of person(s) subject Mr Alberto Colussi to the notification obligation: (iii) --------------------------------------------------------------------- ------------------------------- 4. Full name of shareholder(s) Mr Alberto Colussi (if different from 3.):(iv) Brahma AG --------------------------------------------------------------------- ------------------------------- 5. Date of the transaction and date 19 December 2017 on which the threshold is crossed or reached: (v) --------------------------------------------------------------------- ------------------------------- 6. Date on which issuer notified: 21 December 2017 --------------------------------------------------------------------- ------------------------------- 7. Threshold(s) that is/are crossed Below 12% or reached: (vi, vii) --------------------------------------------------------------------- ------------------------------- 8. Notified details: ---------------------------------------------------------------------------------------------------------------------- A: Voting rights attached to shares (viii, ix) ---------------------------------------------------------------------------------------------------------------------- Class/type Situation previous Resulting situation after the triggering of to the triggering transaction shares transaction if possible using the ISIN CODE ------------- ---------------------------------- ------------------------------------------------------------------- Number Number Number Number of voting % of voting rights of of of shares rights (x) Shares Voting Rights ------------- ---------------- ---------------- -------------- ---------------------- --------------------------- Direct Direct Indirect Direct Indirect (xi) (xii) ------------- ------------ ------------ -------------- --------- ----------- ------------ ------------- Ordinary shares (GBP 0.25) GB00BD6SX109 9,837,306 9,837,306 0 0 9,657,306 0% 11.93% ---------------- ---------------- -------------- --------- ----------- ------------ ------------- B: Qualifying Financial Instruments ---------------------------------------------------------------------------------------------------------------------- Resulting situation after the triggering transaction ---------------------------------------------------------------------------------------------------------------------- Type of Expiration Exercise/ Number of voting % of voting financial date (xiii) Conversion Period rights that may rights instrument (xiv) be acquired if the instrument is exercised/ converted. ----------------- -------------- -------------------------------- ------------------------ ----------------------- N/A ----------------- -------------- -------------------------------- ------------------------ ----------------------- C: Financial Instruments with similar economic effect to Qualifying Financial Instruments (xv, xvi) ---------------------------------------------------------------------------------------------------------------------- Resulting situation after the triggering transaction ---------------------------------------------------------------------------------------------------------------------- Type of Exercise Expiration Exercise/ Number of voting % of voting rights financial price date (xvii) Conversion rights instrument (xix, xx) instrument period refers to (xviii) --------------- -------------- -------------- ---------------- ------------------------ ------------------------- N/A Nominal Delta --------------- -------------- -------------- ---------------- ------------------------ ------------ ----------- Total (A+B+C) ---------------------------------------------------------------------------------------------------------------------- Number of voting rights Percentage of voting rights --------------------------------------------------- ----------------------------------------------------------------- 9,657,306 11.93% --------------------------------------------------- ----------------------------------------------------------------- 9. Chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held, if applicable: (xxi) ----------------------------------------------------------------------------------------------- Mr Alberto Colussi's direct holding in Brahma AG is 100% Proxy Voting: ----------------------------------------------------------------------------------------------- 10. Name of the proxy holder: N/A ----------------------------------------------------------------------- ---------------------- 11. Number of voting rights proxy holder will N/A cease to hold: ----------------------------------------------------------------------- ---------------------- 12. Date on which proxy holder will cease to N/A hold voting rights: ----------------------------------------------------------------------- ---------------------- N/A 13. Additional information: ---------------------------------------------------------------------- ----------------------- 14. Contact name: Graham Pughe, AVO Plc ---------------------------------------------------------------------- ----------------------- 15. Contact telephone number: 0203 761 4995 ----------------------------------------------------------------------- ----------------------
This information is provided by RNS
The company news service from the London Stock Exchange
END
HOLUUUARBSAUUAA
(END) Dow Jones Newswires
December 22, 2017 06:24 ET (11:24 GMT)
1 Year Advanced Oncotherapy Chart |
1 Month Advanced Oncotherapy Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions